b

biote Corp
NASDAQ:BTMD

Watchlist Manager
biote Corp
NASDAQ:BTMD
Watchlist
Price: 2.2014 USD -5.11% Market Closed
Market Cap: 100.5m USD

Operating Margin

16.1%
Current
Improving
by 8.2%
vs 3-y average of 7.9%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
16.1%
=
Operating Income
$31.5m
/
Revenue
$195.6m

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
16.1%
=
Operating Income
$31.5m
/
Revenue
$195.6m

Peer Comparison

Country Company Market Cap Operating
Margin
US
biote Corp
NASDAQ:BTMD
100.5m USD
Loading...
US
Eli Lilly and Co
NYSE:LLY
984.5B USD
Loading...
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP
Loading...
US
Johnson & Johnson
NYSE:JNJ
524.6B USD
Loading...
CH
Roche Holding AG
SIX:ROG
273.4B CHF
Loading...
UK
AstraZeneca PLC
LSE:AZN
209.7B GBP
Loading...
CH
Novartis AG
SIX:NOVN
219B CHF
Loading...
US
Merck & Co Inc
NYSE:MRK
270.4B USD
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.7T DKK
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
US
Pfizer Inc
NYSE:PFE
144.8B USD
Loading...
No Stocks Found

Market Distribution

Higher than 73% of companies in the United States of America
Percentile
73nd
Based on 14 112 companies
73nd percentile
16.1%
Low
-4 087 900% — -5.1%
Typical Range
-5.1% — 14.8%
High
14.8% — 1 032 600%
Distribution Statistics
the United States of America
Min -4 087 900%
30th Percentile -5.1%
Median 6%
70th Percentile 14.8%
Max 1 032 600%

biote Corp
Glance View

Market Cap
100.5m USD
Industry
Pharmaceuticals

biote Corp. is a woman-led company, which engages in providing bio identical hormone pellet therapy. The company is headquartered in Irving, Texas. The company went IPO on 2021-03-02. The firm provides components to enable Biote-certified practitioners to establish, build, and implement a program designed to optimize hormone levels using personalized solutions for their patient populations. Its Biote Method is a comprehensive, end-to-end practice-building platform that provides Biote-certified practitioners with components specifically developed for practitioners in the hormone optimization space, such as Biote Method education, training and certification, practice management software, inventory management software, and information regarding available hormone replacement therapy (HRT) products, as well as digital and point-of-care marketing support. The firm trains practitioners how to identify and treat early indicators of hormone-related aging conditions. The company also sells a complementary Biote-branded line of dietary supplements.

BTMD Intrinsic Value
HIDDEN
Show
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
16.1%
=
Operating Income
$31.5m
/
Revenue
$195.6m
What is biote Corp's current Operating Margin?

The current Operating Margin for biote Corp is 16.1%, which is above its 3-year median of 7.9%.

How has Operating Margin changed over time?

Over the last 3 years, biote Corp’s Operating Margin has increased from -39.3% to 16.1%. During this period, it reached a low of -39.3% on Sep 30, 2022 and a high of 18.7% on Sep 30, 2024.

Back to Top